Get started
Author

Masatoshi Kanayama

Observed names: Kanayama, Masatoshi, MASATOSHI KANAYAMA, Masatoshi KANAYAMA
ORCID: 0000-0001-8812-1787
Observed ORCID: 0000-0001-8812-1787
OpenAlex ID: A5038168757
Alteration in tumoural PD-L1 expression and stromal CD8-positive tumour-infiltrating lymphocytes after concurrent chemo-radiotherapy for non-small cell lung cancer
2019 · Kazue Yoneda, Taiji Kuwata, et al. · British Journal of Cancer · 122
PDF
Prognostic factors of advanced or postoperative recurrent non-small cell lung cancer targeted with immune check point inhibitors
2019 · Yoshinobu Ichiki, Akihiro Taira, et al. · Journal of Thoracic Disease · 45
PDF
Prognostic impact of PD-L1 expression in correlation with neutrophil-to-lymphocyte ratio in squamous cell carcinoma of the lung
2020 · Yuko Tashima, Taiji Kuwata, et al. · Scientific Reports · 34
PDF
Perioperative pirfenidone treatment for lung cancer patients with idiopathic pulmonary fibrosis
2019 · Masatoshi Kanayama, Masataka Mori, et al. · Surgery Today · 34
CD155 expression and its clinical significance in non‑small cell lung cancer
2022 · Rintaro Oyama, Masatoshi Kanayama, et al. · Oncology Letters · 32
PDF
Detection of Circulating Tumor Cells (CTCs) in Malignant Pleural Mesothelioma (MPM) with the “Universal” CTC-Chip and An Anti-Podoplanin Antibody NZ-1.2
2020 · Taiji Kuwata, Kazue Yoneda, et al. · Cells · 30
PDF
Detection of circulating tumor cells with a novel microfluidic system in malignant pleural mesothelioma
2018 · Kazue Yoneda, Taiji Kuwata, et al. · Cancer Science · 29
PDF
Prognostic impact of circulating tumor cells detected with the microfluidic “universal CTC‐chip” for primary lung cancer
2021 · Masatoshi Kanayama, Taiji Kuwata, et al. · Cancer Science · 23
Squamous cell carcinoma transformation from adenocarcinoma as an acquired resistance after the EGFR TKI therapy in (EGFR-mutated) non-small cell lung cancer
2018 · Shinji Shinohara, Yoshinobu Ichiki, et al. · Journal of Thoracic Disease · 22
PDF
Effect of erlotinib plus bevacizumab on brain metastases in patients with non-small cell lung cancer
2018 · Yasuhiro Chikaishi, Masatoshi Kanayama, et al. · Annals of Translational Medicine · 20
PDF
Enhanced capture system for mesenchymal‑type circulating tumor cells using a polymeric microfluidic device ‘CTC‑Chip’ incorporating cell‑surface vimentin
2024 · Masatoshi Kanayama, Kazue Yoneda, et al. · Oncology Reports · 16
PDF
Predictive factors of postoperative survival among patients with pulmonary neuroendocrine tumor
2018 · Yoshinobu Ichiki, Hiroki Matsumiya, et al. · Journal of Thoracic Disease · 16
PDF
Prognostic impact of PD-L1 and TIGIT expression in non-small cell lung cancer following concurrent chemo-radiotherapy
2023 · Masataka Mori, Masatoshi Kanayama, et al. · Scientific Reports · 12
PDF
Robot-assisted thoracoscopic resection of a posterior mediastinal tumor with preserving the artery of Adamkiewicz
2022 · Yukiko Nemoto, Koji Kuroda, et al. · Surgical Case Reports · 11
PDF
Thoracoscopic Lung Lobectomy for a Lung Cancer Patient with Situs Inversus Totalis
2018 · Masatoshi KANAYAMA, Masaaki INOUE, et al. · Journal of UOEH · 11
PDF
Relationship between anti-acetylcholine receptor antibodies and the development of post-thymectomy myasthenia gravis in patients with thymoma: a single-center experience
2021 · Yusuke Nabe, Teppei Hashimoto, et al. · Gland Surgery · 10
PDF
Novel circulating tumor cell‑detection chip combining conventional podoplanin and EGFR antibodies for all histological malignant pleural mesothelioma
2021 · Masatoshi Kanayama, Rintaro Oyama, et al. · Oncology Letters · 9
PDF
What is the best treatment strategy for primary spontaneous pneumothorax? A retrospective study
2019 · Yasuhiro Chikaishi, Masatoshi Kanayama, et al. · Annals of Medicine and Surgery · 5
PDF
Immune checkpoint inhibitors in the treatment of pleural mesothelioma: insights from real-world data
2025 · Masatoshi Kanayama, Takehiko Manabe, et al. · International Journal of Clinical Oncology · 4
Outcomes and pathologic response of primary lung cancer treated with tyrosine kinase inhibitor/immune checkpoint inhibitor before salvage surgery
2024 · Masaru Takenaka, Fumihiro Tanaka, et al. · Surgery Today · 4
Non-incisional pleurectomy/decortication for malignant pleural mesothelioma
2021 · Fumihiro Tanaka, Masaru Takenaka, et al. · General Thoracic and Cardiovascular Surgery · 4
The surgical technique for complete resection of lung cancer invading the intrapericardial pulmonary vein and left atrium
2020 · Koji Kuroda, Masataka Mori, et al. · Surgery Today · 4
Alteration in tumor immune microenvironment after chemo-radiotherapy for locally advanced non-small cell lung cancer.
2019 · Kazue Yoneda, Taiji Kuwata, et al. · Journal of Clinical Oncology · 4
Modified risk scoring system for acute exacerbation of interstitial lung disease
2018 · Masatoshi Kanayama, Toshihiro Osaki, et al. · Asian Cardiovascular and Thoracic Annals · 4
Idiopathic spontaneous pulmonary torsion of the lingula: A case report
2017 · Masatoshi Kanayama, Toshihiro Osaki, et al. · International Journal of Surgery Case Reports · 4
Works count: 75
Citation count: 547
H-index: 12
I10-index: 16
Year
Topic
Type